Literature DB >> 8189498

Identification of an immediate-early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide.

Y Hong1, P M Coussens.   

Abstract

Marek's disease virus (MDV) is an oncogenic avian herpesvirus whose genomic structure is similar to those of herpes simplex virus and varicella-zoster virus. Repeat regions of the MDV genome have been intensively investigated because of a potential relationship to MDV oncogenicity and abundant expression of immediate-early transcripts. In this study, a 1.6-kb immediate-early transcript was localized to the BamHI-I2 region by Northern (RNA) hybridization analysis. With cDNA cloning and sequencing, two cDNAs of 1.4 kb (C1) and 1.35 kb (C2) were identified. Both cDNAs are derived from spliced mRNAs spanning the BamHI-H and -I2 fragments. C1 and C2 use the same splice acceptors and 3' ends, but they differ at their 5' ends and utilize different splice donors. The upstream promoter-enhancer region of C1 cDNA has been defined as a bidirectional regulatory region shared by the MDV pp38 gene. Sequencing analysis shows two small open reading frames (ORFs) within each cDNA (ORF1a and ORF2 in C1, ORF1b and ORF2 in C2). Potential ORFs of the sequence have no significant homology with any known protein in the Swiss-Protein data base. DNA fragments encoding ORF1a and ORF1b were cloned into pGEX-3X vectors to produce glutathione S-transferase fusion proteins and induce antisera. In Western blot (immunoblot) analysis of MDV-infected-cell lysates, a 14-kDa polypeptide was identified by antisera against both ORF1a and ORF1b. This 14-kDa protein is expressed in cells which are lytically infected with MDV strains GA, Md11 passage 14 (oncogenic), and Md11 passage 83 (attenuated), as well as in the latently MDV-infected and transformed MSB-1 cell line.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189498      PMCID: PMC236863     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  A simple, efficient method to create a cDNA library.

Authors:  W N Hu; W Kopachik; R N Band
Journal:  Biotechniques       Date:  1992-12       Impact factor: 1.993

Review 2.  Structural features in eukaryotic mRNAs that modulate the initiation of translation.

Authors:  M Kozak
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

3.  Isolation and characterization of cDNAs from BamHI-H gene family RNAs associated with the tumorigenicity of Marek's disease virus.

Authors:  F Peng; G Bradley; A Tanaka; G Lancz; M Nonoyama
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Selective inhibition by phosphonoacetic acid of MDV DNA replication in a lymphoblastoid cell line.

Authors:  K Nazerian; L F Lee
Journal:  Virology       Date:  1976-10-01       Impact factor: 3.616

5.  Two cell lines from lymphomas of Marek's disease.

Authors:  Y Akiyama; S Kato
Journal:  Biken J       Date:  1974-09

6.  Agent of Marek's disease in tissue culture.

Authors:  A E Churchill; P M Biggs
Journal:  Nature       Date:  1967-07-29       Impact factor: 49.962

7.  Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells.

Authors:  Z Z Cui; L F Lee; J L Liu; H J Kung
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Characterization of a bovine herpesvirus 4 immediate-early RNA encoding a homolog of the Epstein-Barr virus R transactivator.

Authors:  V L van Santen
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

9.  Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors.

Authors:  D Jones; L Lee; J L Liu; H J Kung; J K Tillotson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  Molecular analysis of the glycoprotein C-negative phenotype of attenuated Marek's disease virus.

Authors:  M R Wilson; R A Southwick; J T Pulaski; V L Tieber; Y Hong; P M Coussens
Journal:  Virology       Date:  1994-03       Impact factor: 3.616

View more
  13 in total

1.  The genome of a very virulent Marek's disease virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein.

Authors:  Z Qian; P Brunovskis; L Lee; P K Vogt; H J Kung
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

3.  Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome.

Authors:  M S Parcells; R L Dienglewicz; A S Anderson; R W Morgan
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 4.  The Leeuwenhoek Lecture, 1997. Marek's disease herpesvirus: oncogenesis and prevention.

Authors:  P M Biggs
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-12-29       Impact factor: 6.237

5.  Identification of an intercistronic internal ribosome entry site in a Marek's disease virus immediate-early gene.

Authors:  Abdessamad Tahiri-Alaoui; Lorraine P Smith; Suzan Baigent; Lydia Kgosana; Lawrence J Petherbridge; Luke S Lambeth; William James; Venugopal Nair
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

6.  Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.

Authors:  E Le Rouzic; P Thoraval; M Afanassieff; Y Cherel; G Dambrine; B Perbal
Journal:  Mol Pathol       Date:  2002-08

7.  The 5' leader of the mRNA encoding the marek's disease virus serotype 1 pp14 protein contains an intronic internal ribosome entry site with allosteric properties.

Authors:  Abdessamad Tahiri-Alaoui; Daiki Matsuda; Hongtao Xu; Panopoulos Panagiotis; Luke Burman; Luke S Lambeth; Lawrence Petherbridge; William James; Vincent Mauro; Venugopal Nair
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

8.  Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells.

Authors:  Alon M Levy; Yoshihiro Izumiya; Peter Brunovskis; Liang Xia; Mark S Parcells; Sanjay M Reddy; Lucy Lee; Hong-Wu Chen; Hsing-Jien Kung
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes.

Authors:  M S Parcells; A S Anderson; T W Morgan
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Deletion of the Meq gene significantly decreases immunosuppression in chickens caused by pathogenic Marek's disease virus.

Authors:  Yanpeng Li; Aijun Sun; Shuai Su; Peng Zhao; Zhizhong Cui; Hongfei Zhu
Journal:  Virol J       Date:  2011-01-05       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.